Though PRDX2 did not predict HNSCC prognosis, we still found that PRDX2 was positively associated with aggressive phenotype, such as angiogenesis, EMT, invasion, metastasis and proliferation, which was in line with oral squamous cell carcinoma (OSCC). This evidence concerns the gene PRDX2 and head and neck squamous cell carcinoma.